Calmare TherapeuticsCTTC
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Calmare Therapeutics Inc. (CTTC) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was Jackson Wealth Management, LLC ($0).
- Company
- Calmare Therapeutics Inc.
- CUSIP
- 13126R102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Jackson Wealth Management, LLC | 0.00% | No change | 126,906 | $0 |
"% of holder's portfolio" is CTTC's weight in each manager's 13F, not the share of Calmare Therapeutics Inc. the manager owns.